This semester, 28 first-year Larner College of Medicine students are learning about culinary medicine, which pairs nutritional science with preventative health care. Medical class of 2026 students Sarah Krumholz and Molly Hurd developed an extracurricular course that teaches classmates about lifestyle interventions for chronic disease.

Autoimmune disease is frequent in patients with myelodysplastic syndromes, but studies have been inconclusive about how the preexistence of autoimmunity affects survival in these patients. A new study by UVM Cancer Center member Diego Adrianzen Herrera, M.D. uses an epidemiologic analysis to clarify that issue.

A new collaboration between Vermont Medicaid and UVM Medical Center’s Comprehensive Pain Program allows Medicaid members with chronic pain to participate in complementary therapies including health coaching, massage, yoga, nutrition, acupuncture, and meditation. This pilot is an important step toward eliminating disparities in access to effective, integrative care for pain.

(OCTOBER 16, 2023) Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.

To reduce barriers to skin cancer screening, the University of Vermont Cancer Center works with the UVM Cancer Center’s community advisory board member, Chief Donald Stevens, tribal leader for the Nulhegan Band of the Coosuk Abenaki Nation to bring skin checks out to communities in Vermont.

(OCTOBER 2, 2023) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, commented to WCAX about the annual Women’s Health and Cancer Conference held at UVM on September 29.

(SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.

Research by Yvonne Janssen-Heininger, Ph.D., and Reem Aboushousha, Ph.D, uncovered a novel facet of glutaredoxin, a prominent player in humans’ antioxidant defense system . The findings bear substantial implications in the field of cancer biology.

Each summer, many rising second-year medical students engage in clinical, basic science or health policy-related research projects under the guidance of expert faculty. The students choose their topics based on personal passions and immerse themselves in projects tackling medical puzzles and unmet health needs. Engaging in research can be among the most valuable experiences during a medical education.

Kristin Flanary, known internationally as her social media alter ego, Lady Glaucomflecken, is on a mission to make health care a little more human. Through storytelling, her keynote address on September 29 at the Women’s Health and Cancer Conference will highlight her perspective as a caregiver and “co-survivor” of her husband’s two cancer occurrences and sudden cardiac arrest.

(AUGUST 3, 2023) At the 2023 International Mesothelioma Interest Group (iMig) conference in June, Brian Cunniff, Ph.D., assistant professor of pathology, presented early experience with “an exciting new therapeutic option for patients suffering with mesothelioma” to a global audience of clinicians, scientists, and allied professionals, according to Business Wire.

Thanks to positive results from a new clinical trial in which the UVM Cancer Center and Chris Holmes, M.D., Ph.D., professor of medicine, played a role, the five to 25 percent of cancer patients who develop venous thrombosis will no longer need to inject themselves with a blood thinner.

This summer, 20 summer scholars were awarded $4,000 stipends to deepen their engagement, hone their skills, and drive towards new discoveries under the guidance of a UVM Cancer Center mentor. Among the group is Kanayo Ikeh, this year’s 2023 Juckett Summer Student Scholar.